Taken together, these findings demonstrate an important role of FGF21 as a hepatic hormone in the regulation of lipid metabolism and also suggest that FGF21exhibits the therapeutic characteristic necessary for an effective treatment of obesity and fatty liver disease. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.